theory clinical_39_7
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  TTKInhibitor :: "entity ⇒ bool"
  Has :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Block :: "event ⇒ bool"
  Activity :: "event ⇒ bool"
  CTNNB :: "entity ⇒ bool"
  Reduce :: "event ⇒ bool"
  EffectiveIn :: "entity ⇒ entity ⇒ bool"
  Contribute :: "event ⇒ bool"
  Directly :: "event ⇒ bool"
  Ensure :: "event ⇒ bool"

(* Explanation 1: This patient has an activating mutation in CTNNB1, and TTK inhibitors block the activity of CTNNB. Blocking the activity of CTNNB1 is necessary and sufficient to reduce the effects of activating mutations in CTNNB. Reducing the effects of activating mutations in CTNNB1 is necessary and sufficient for TTK inhibitors to be effective in patients with such mutations. *)
axiomatization where
  explanation_1: "∃x y z e1 e2 e3 e4. Patient x ∧ Mutation y ∧ CTNNB1 y ∧ TTKInhibitor z ∧ Has e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Block e2 ∧ Agent e2 z ∧ Activity e3 ∧ CTNNB y ∧ Agent e2 y ∧ (Block e4 ∧ Agent e4 y ⟶ Reduce e4 ∧ Agent e4 y) ∧ (Reduce e4 ∧ Agent e4 y ⟶ EffectiveIn z x)"

(* Explanation 2: If a patient has an activating mutation in CTNNB1 and TTK inhibitors block the activity of CTNNB1, then blocking the activity leads to reducing the effects of these mutations, which is necessary and sufficient for making TTK inhibitors effective in this patient. *)
axiomatization where
  explanation_2: "∀x y z e1 e2 e3 e4. (Patient x ∧ Mutation y ∧ CTNNB1 y ∧ TTKInhibitor z ∧ Has e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Block e2 ∧ Agent e2 z ∧ Activity e3 ∧ CTNNB1 y ∧ Agent e2 y) ⟶ (Block e4 ∧ Agent e4 y ⟶ Reduce e4 ∧ Agent e4 y ∧ (Reduce e4 ∧ Agent e4 y ⟶ EffectiveIn z x))"

(* Explanation 3: Blocking the activity of CTNNB1 directly contributes to and ensures the effectiveness of TTK inhibitors in patients with activating mutations in CTNNB. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3. Patient x ∧ Mutation y ∧ CTNNB y ∧ TTKInhibitor z ∧ Activity e1 ∧ CTNNB1 y ∧ Block e2 ∧ Agent e2 y ∧ Contribute e2 ∧ Directly e2 ∧ Ensure e3 ∧ EffectiveIn z x ∧ Agent e3 y"

theorem hypothesis:
  assumes asm: "TTKInhibitor x ∧ Patient y"
  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)
  shows "∃x y. TTKInhibitor x ∧ Patient y ∧ EffectiveIn x y"
proof -
  (* From the premise, we have known information about TTK Inhibitor and Patient. *)
  from asm have "TTKInhibitor x ∧ Patient y" by simp
  (* Explanation 2 provides a logical relation: If a patient has an activating mutation in CTNNB1 and TTK inhibitors block the activity of CTNNB1, then blocking the activity leads to reducing the effects of these mutations, which is necessary and sufficient for making TTK inhibitors effective in this patient. *)
  (* We can use the logical relation Implies(C, E) from Explanation 1: Implies(blocking the activity of CTNNB1, TTK inhibitors are effective in patients with activating mutations in CTNNB1) *)
  (* Since Explanation 2 implies that blocking the activity leads to effectiveness, we can infer that TTK inhibitors are effective in this patient. *)
  then have "EffectiveIn x y" sledgehammer
  then show ?thesis <ATP>
qed

end
